Efficient downregulation of DPH2 and induction of resistance to DT was confirmed in three additional human cancer cell lines derived from different tissues and in a non-transformed human breast epithelial cell line (Fig. 1b, Supplementary Table 2). The gene discussed is DPH2; the disease is cancer.